{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:44:24Z","timestamp":1793411064381,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jaad.2014.03.034","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T06:35:26Z","timestamp":1398321326000},"page":"795-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Recognizing and managing the immunologic reactions\u00a0in leprosy"],"prefix":"10.1016","volume":"71","author":[{"given":"Sonia","family":"Kamath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A.","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.03.034_bib1","unstructured":"World Health Organization. WHO Expert Committee on Leprosy. World Health Organ Tech Rep Ser 2012;968:1-61."},{"key":"10.1016\/j.jaad.2014.03.034_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1473-3099(11)70006-8","article-title":"Leprosy now: epidemiology, progress, challenges, and research gaps","volume":"11","author":"Rodrigues","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.47276\/lr.79.4.372","article-title":"Leprosy type 1 (reversal) reactions and their management","volume":"79","author":"Walker","year":"2008","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(87)70164-9","article-title":"Leprosy: new insight into an ancient disease","volume":"17","author":"Modlin","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-4362.1996.tb03016.x","article-title":"Erythema nodosum leprosum","volume":"35","author":"Meyerson","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archderm.1978.01640190011004","article-title":"Lucio\u2019s phenomenon and diffuse nonnodular lepromatous leprosy","volume":"114","author":"Rea","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1346-8138.2004.tb00623.x","article-title":"A study of leprosy reactions in a tertiary hospital in Delhi","volume":"31","author":"Sharma","year":"2004","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib8","first-page":"270","article-title":"Risk factors for erythema nodosum leprosum","volume":"67","author":"Manandhar","year":"1999","journal-title":"Int J Lepro Other Mycobact Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.5858\/2007-131-982-HDITUS","article-title":"Hansen disease in the United States in the 21st century","volume":"131","author":"Anderson","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaad.2014.03.034_bib10","series-title":"National Hansen's Disease Program. A summary of Hansen's disease in the United States-2009","year":"2011"},{"key":"10.1016\/j.jaad.2014.03.034_bib11","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJMoa1010536","article-title":"Probable zoonotic leprosy in the Southern United States","volume":"364","author":"Truman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2014.03.034_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S0365-05962008000100010","article-title":"Leprosy type 1 reactions and erythema nodosum leprosum","volume":"83","author":"Kahawita","year":"2008","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-4362.1987.tb00188.x","article-title":"Reactions in leprosy: clinical aspects","volume":"26","author":"Sehgal","year":"1987","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00007611-199102000-00021","article-title":"Reactional states in\u00a0Hansen\u2019s disease: practical aspects of emergency management","volume":"84","author":"Goodless","year":"1991","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2014.03.034_bib15","first-page":"277","article-title":"The INFIR cohort study: assessment of\u00a0sensory and motor neuropathy in leprosy at baseline","volume":"76","author":"Van Brakel","year":"2005","journal-title":"Lepr\u00a0Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0140-6736(91)91232-J","article-title":"Patients, risk factors for type 1 reactions in borderline leprosy","volume":"338","author":"Roche","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2014.03.034_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2003.11.072","article-title":"An update on the diagnosis and treatment of leprosy","volume":"51","author":"Moschella","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib18","first-page":"143","article-title":"The significance of facial patches and type I reaction for the development of facial nerve damage in leprosy: a retrospective study among 1226 paucibacillary leprosy patients","volume":"62","author":"Hogeweg","year":"1991","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib19","first-page":"102","article-title":"Ocular changes in reactions in leprosy","volume":"60","author":"Shorey","year":"1989","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-4362.1990.tb03793.x","article-title":"Ocular changes in leprosy","volume":"29","author":"Sehgal","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib21","first-page":"6","article-title":"Pregnancy and leprosy: a\u00a0comprehensive literature review","volume":"67","author":"Lockwood","year":"1999","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.47276\/lr.74.4.366","article-title":"WHO disability grading: operational definitions","volume":"74","author":"Brandsma","year":"2003","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib23","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1371\/journal.pntd.0000921","article-title":"Granulomatous reactivation during the course of a leprosy infection: reaction or relapse","volume":"4","author":"Trindade","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib24","first-page":"203","article-title":"Borderline tuberculoid leprosy with type 1 reaction in an HIV patient\u2013a phenomenon of immune reconstitution","volume":"73","author":"Narang","year":"2005","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1258\/ijsa.2007.007163","article-title":"Immune reconstitution syndrome associated with leprosy: two cases","volume":"19","author":"Deps","year":"2008","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2014.03.034_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/QAD.0b013e3283291405","article-title":"Leprosy reaction as a manifestation of immune reconstitution inflammatory syndrome: a case series of a Brazilian cohort","volume":"23","author":"Menezes","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2014.03.034_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1473-3099(06)70493-5","article-title":"Interactions between HIV infection and leprosy: a paradox","volume":"6","author":"Ustianowski","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1586\/eri.11.44","article-title":"Leprosy and HIV coinfection: a critical approach","volume":"9","author":"Massone","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jaad.2014.03.034_bib29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/003335490812300213","article-title":"HIV-M leprae interaction: can HAART modify the course of leprosy?","volume":"123","author":"Sarno","year":"2008","journal-title":"Public Health Rep"},{"key":"10.1016\/j.jaad.2014.03.034_bib30","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1086\/505222","article-title":"Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases","volume":"43","author":"Scollard","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archdermatol.2009.10","article-title":"Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy","volume":"145","author":"Camacho","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/2013.jamadermatol.503","article-title":"Immune reconstitution reactions in human immunodeficiency virus\u2013negative patients","volume":"149","author":"Scharschmidt","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyg225","article-title":"Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up","volume":"33","author":"Richardus","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaad.2014.03.034_bib34","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1371\/journal.pntd.0000351","article-title":"Development and validation of a severity scale for leprosy type 1 reactions","volume":"2","author":"Walker","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib35","first-page":"305","article-title":"Reliability of Semmes Weinstein monofilament and ballpoint sensory testing, and voluntary muscle testing in Bangladesh","volume":"70","author":"Anderson","year":"1999","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.47276\/lr.79.3.277","article-title":"Voluntary muscle testing and dynamometry in diagnosis of motor impairment in leprosy: a comparative study within the INFIR cohort study","volume":"79","author":"Suresh","year":"2008","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib37","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jcp.2007.053389","article-title":"The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis","volume":"61","author":"Lockwood","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaad.2014.03.034_bib38","doi-asserted-by":"crossref","first-page":"e1702","DOI":"10.1371\/journal.pntd.0001702","article-title":"Comparing the clinical and histological diagnosis of leprosy and leprosy reactions in the INFIR cohort of Indian patients with multibacillary leprosy","volume":"6","author":"Lockwood","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-4362.1988.tb04919.x","article-title":"Immunology of reactions in leprosy","volume":"27","author":"Sehgal","year":"1988","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1073\/pnas.90.1.188","article-title":"Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen","volume":"90","author":"Wang","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2014.03.034_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4269\/ajtmh.2002.66.409","article-title":"The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions","volume":"66","author":"Lockwood","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2014.03.034_bib42","first-page":"623","article-title":"Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy","volume":"55","author":"Narayanan","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2014.03.034_bib43","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/IAI.69.5.3413-3417.2001","article-title":"Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment","volume":"69","author":"Little","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2014.03.034_bib44","doi-asserted-by":"crossref","first-page":"e1327","DOI":"10.1371\/journal.pntd.0001327","article-title":"Cytokine and protein markers of leprosy reactions in skin and nerves: baseline results for the North Indian INFIR cohort","volume":"5","author":"Lockwood","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/CVI.00042-11","article-title":"Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions","volume":"18","author":"Scollard","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaad.2014.03.034_bib46","first-page":"103","article-title":"Serum levels of tumor necrosis factor-alpha and interleukin-1 beta during leprosy reactional states","volume":"84","author":"Sarno","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2014.03.034_bib47","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1128\/IAI.71.3.1427-1433.2003","article-title":"Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy","volume":"71","author":"Oliveira","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2014.03.034_bib48","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1371\/journal.pntd.0000231","article-title":"Human TLR1 deficiency is associated with\u00a0impaired mycobacterial signaling and protection from\u00a0leprosy reversal reaction","volume":"2","author":"Misch","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib49","doi-asserted-by":"crossref","first-page":"e1869","DOI":"10.1371\/journal.pntd.0001869","article-title":"Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions","volume":"6","author":"Cogen","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib50","first-page":"285","article-title":"The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors, and outcome","volume":"71","author":"Saunderson","year":"2000","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib51","first-page":"154","article-title":"The treatment of acute nerve function impairment in leprosy: results from a prospective cohort study in Bangladesh","volume":"71","author":"Croft","year":"2000","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/PHAR.1009","article-title":"Hansen\u2019s disease (leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions","volume":"32","author":"Legendre","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaad.2014.03.034_bib53","unstructured":"Health Resources and Services Administration. Managing reactions. Available from: URL:http:\/\/www.hrsa.gov\/hansensdisease\/diagnosis\/reactions.html. Accessed November 29, 2013."},{"key":"10.1016\/j.jaad.2014.03.034_bib54","first-page":"125","article-title":"A study of steroid-induced diabetes mellitus in leprosy","volume":"81","author":"Papang","year":"2009","journal-title":"Indian J Lepr"},{"key":"10.1016\/j.jaad.2014.03.034_bib55","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archdermatol.2011.79","article-title":"Off-label use of azathioprine in dermatology: a systematic review","volume":"147","author":"Schram","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib56","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.trstmh.2003.12.013","article-title":"Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal","volume":"98","author":"Marlowe","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2014.03.034_bib57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.trstmh.2006.11.010","article-title":"Response to cyclosporin treatment in Ethiopian and Nepali patients with severe leprosy type 1 reactions","volume":"101","author":"Marlowe","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2014.03.034_bib58","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/518699","article-title":"Methotrexate treatment for type 1 (reversal) leprosy reactions","volume":"45","author":"Biosca","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/0019-5359.55888","article-title":"Type 1 leprosy reversal reaction treated with topical tacrolimus along with systemic corticosteroids","volume":"63","author":"Safa","year":"2009","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.jaad.2014.03.034_bib60","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1084\/jem.175.6.1729","article-title":"Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients","volume":"175","author":"Sampaio","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2014.03.034_bib61","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.1975.01630240031005","article-title":"Erythema nodosum leprosum in a general hospital","volume":"111","author":"Rea","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.47276\/lr.83.1.98","article-title":"Florid reactive periostitis ossificans of long bones and digits associated with reaction in a patient with leprosy","volume":"83","author":"Chakma","year":"2012","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.trstmh.2008.01.004","article-title":"Towards understanding the pathology of erythema nodosum leprosum","volume":"102","author":"Kahawita","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jaad.2014.03.034_bib64","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-4362.1992.tb03981.x","article-title":"Reaction in leprosy: acute phase reactant response during and after remission","volume":"31","author":"Sehgal","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0560.2009.01404.x","article-title":"Panniculitis: clinical overlap and the significance of biopsy findings","volume":"37","author":"Chopra","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2014.03.034_bib66","first-page":"558","article-title":"Integrated pathways for neutrophil recruitment and inflammation in leprosy","volume":"201","author":"Lee","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib67","first-page":"17","article-title":"In situ characterization of T-lymphocyte subsets in the reactional states of leprosy","volume":"53","author":"Modlin","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2014.03.034_bib68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2567.1998.00634.x","article-title":"Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions","volume":"95","author":"Sreenivasan","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.jaad.2014.03.034_bib69","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-2249.2000.01376.x","article-title":"Production of transforming growth factor-beta-1 by blood monocytes from patients with different clinical forms of leprosy","volume":"122","author":"Goulart","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2014.03.034_bib70","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/infdis\/jis208","article-title":"Genetic and immunological evidence implicates interleukin 6 as a susceptibility gene for leprosy type 2 reaction","volume":"205","author":"Sousa","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib71","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2014.03.034_bib72","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation","volume":"192","author":"Haslett","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0149-2918(00)88289-2","article-title":"S.T.E.P.S.TM: A\u00a0comprehensive program for controlling and monitoring access to thalidomide","volume":"21","author":"Zeldis","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2014.03.034_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.47276\/lr.78.3.197","article-title":"The role of thalidomide in the management of erythema nodosum leprosum","volume":"78","author":"Walker","year":"2007","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib75","first-page":"765","article-title":"Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature","volume":"8","author":"Fabi","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib76","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1346-8138.2011.01484.x","article-title":"Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy","volume":"39","author":"Yamaguchi","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.47276\/lr.79.2.193","article-title":"A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide","volume":"79","author":"Vetrichevvel","year":"2008","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib78","doi-asserted-by":"crossref","first-page":"228","DOI":"10.47276\/lr.81.3.228","article-title":"Review of leprosy research evidence (2002-2009) and implications for current policy and practice","volume":"81","author":"Van Brakel","year":"2010","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib79","doi-asserted-by":"crossref","first-page":"355","DOI":"10.47276\/lr.80.4.355","article-title":"Interventions for erythema nodosum leprosum: a Cochrane review","volume":"80","author":"Van Veen","year":"2009","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1590\/S0100-879X2007000200011","article-title":"Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy","volume":"40","author":"Sales","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jaad.2014.03.034_bib81","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/cid\/ciq213","article-title":"Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept","volume":"52","author":"Ramien","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib82","first-page":"105","article-title":"Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients","volume":"84","author":"Hossain","year":"2013","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaad.2014.03.034_bib83","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10067-011-1903-2","article-title":"Development of lepromatous leprosy following etanercept treatment for arthritis","volume":"31","author":"Lydakis","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib84","first-page":"602","article-title":"Lucio\u2019s phenomenon\/erythema necroticans","volume":"44","author":"Sehgal","year":"2005","journal-title":"Int\u00a0J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MAJ.0b013e31826af5fb","article-title":"Severe leprosy reactions due to Mycobacterium lepromatosis","volume":"345","author":"Han","year":"2013","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaad.2014.03.034_bib86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00124743-200008000-00008","article-title":"Lucio\u2019s phenomenon: report of two cases and review of the literature","volume":"6","author":"Roverano","year":"2000","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib87","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archderm.1980.01640260077020","article-title":"Lucio\u2019s phenomenon","volume":"116","author":"Pursley","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib88","first-page":"169","article-title":"Clinical and histologic variations among thirty patients with Lucio\u2019s phenomenon and pure and primitive diffuse lepromatosis (Latapi's lepromatosis)","volume":"73","author":"Rea","year":"2005","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib89","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/mjd.2003.326","article-title":"Fatal Lucio\u2019s phenomenon in 2 patients with previously undiagnosed leprosy","volume":"48","author":"Ang","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.03.034_bib90","first-page":"161","article-title":"Lucio\u2019s phenomenon: a comparative histological study","volume":"47","author":"Rea","year":"1979","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.jaad.2014.03.034_bib91","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/DAD.0b013e318181270a","article-title":"Lucio's phenomenon is a necrotizing panvasculitis: mostly a medium-sized granulomatous arteritis","volume":"30","author":"Magana","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2014.03.034_bib92","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1309\/AJCPP72FJZZRRVMM","article-title":"A new Mycobacterium species causing diffuse lepromatous leprosy","volume":"130","author":"Han","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2014.03.034_bib93","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-98-1-49","article-title":"Auricular chondritis as a rheumatologic manifestation of Lucio's phenomenon: clinical improvement after plasmapheresis","volume":"98","author":"Piepkorn","year":"1983","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214012687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214012687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:32:58Z","timestamp":1759271578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214012687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0190962214012687"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.03.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognizing and managing the immunologic reactions\u00a0in leprosy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}